134 related articles for article (PubMed ID: 10817578)
1. Apoptosis of CD4+ T cells in Sjögren's syndrome: comment on the article by Zeher et al.
Kazkaz H
Arthritis Rheum; 2000 May; 43(5):1187-8. PubMed ID: 10817578
[No Abstract] [Full Text] [Related]
2. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
Zeher M; Szodoray P; Gyimesi E; Szondy Z
Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Arthritis Rheum; 2001 Feb; 44(2):490. PubMed ID: 11229485
[No Abstract] [Full Text] [Related]
4. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
5. Increased percentage of CD8+CD28- T cells correlates with clinical activity in primary Sjögren's syndrome.
Smoleńska Z; Pawłowska J; Zdrojewski Z; Daca A; Bryl E
Cell Immunol; 2012; 278(1-2):143-51. PubMed ID: 22975109
[TBL] [Abstract][Full Text] [Related]
6. Immunopathology of Sjögren's syndrome.
Tapinos NI; Polihronis M; Tzioufas AG; Skopouli FN
Ann Med Interne (Paris); 1998 Feb; 149(1):17-24. PubMed ID: 11490512
[TBL] [Abstract][Full Text] [Related]
7. [Immunopathology of Gougerot-Sjogren syndrome].
Youinou P; Mariette X
Rev Prat; 2001 Jan; 51(2):165-70. PubMed ID: 11252942
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-related Fas antigen and in vitro apoptosis of lymphocyte subsets from patients with primary Sjögren's syndrome: comment on the article by Lorenz et al.
Zeher M; Gyimesi E; Szodoray P; Szondy Z
Arthritis Rheum; 1997 Oct; 40(10):1912. PubMed ID: 9336438
[No Abstract] [Full Text] [Related]
10. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis in Sjögren's syndrome.
Bolstad AI; Jonsson R
Ann Med Interne (Paris); 1998 Feb; 149(1):25-9. PubMed ID: 11490513
[TBL] [Abstract][Full Text] [Related]
12. [Sjogren's syndrome--molecular mechanism of the etiology and the specific regulatory therapy].
Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Jun; 22(3):101-10. PubMed ID: 11126661
[No Abstract] [Full Text] [Related]
13. Opportunistic infection due to unexplained CD4+ lymphocytopenia and associated Sjögren's syndrome.
Schattner A; Friedman J; Bentwich Z
Rheumatology (Oxford); 2004 Jan; 43(1):111-2. PubMed ID: 14681566
[No Abstract] [Full Text] [Related]
14. Chemokine receptor expression by peripheral blood B lymphocytes in patients with primary Sjögren's syndrome: comment on the article by Hansen et al.
Perucha E; Reyes E; Prieto A; Alvarez de Mon M; Rodríguez A; Zea A
Arthritis Rheum; 2006 May; 54(5):1707-8; author reply 1708. PubMed ID: 16646060
[No Abstract] [Full Text] [Related]
15. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome.
Papiris SA; Saetta M; Turato G; La Corte R; Trevisani L; Mapp CE; Maestrelli P; Fabbri LM; Potena A
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):637-41. PubMed ID: 9279251
[TBL] [Abstract][Full Text] [Related]
16. [Sjögren's Syndrome and its unrevealed secrets].
Patto JV
Acta Reumatol Port; 2008; 33(4):389-92. PubMed ID: 19107083
[No Abstract] [Full Text] [Related]
17. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation.
Koarada S; Haruta Y; Mitamura M; Morito F; Tada Y; Ohta A; Nagasawa K
Rheumatology (Oxford); 2006 Apr; 45(4):392-9. PubMed ID: 16287915
[TBL] [Abstract][Full Text] [Related]
18. The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al.
Airoldi I; Di Carlo E; Pistoia V
Arthritis Rheum; 2010 Jul; 62(7):2180; author reply 2180-1. PubMed ID: 20506334
[No Abstract] [Full Text] [Related]
19. CD4 cytopenia and occasional expansion of CD4+CD8+lymphocytes in Sjögren's syndrome.
Ferraccioli GF; Tonutti E; Casatta L; Pegoraro I; De Vita S; Sala P; Ravaioli T; Bartoli E
Clin Exp Rheumatol; 1996; 14(2):125-30. PubMed ID: 8737717
[TBL] [Abstract][Full Text] [Related]
20. The existence of human TII B cells remains unproven: comment on the article by Daridon et al.
Sims G; Lipsky P
Arthritis Rheum; 2007 Mar; 56(3):1035-6. PubMed ID: 17330259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
